Take a fresh look at your lifestyle.

The Wall Street Journal: Abbott Laboratories under SEC and FTC investigation over baby-formula business

The Securities and Exchange Commission and Federal Trade Commission are investigating Abbott Laboratories’ baby-formula business, the company said.

The SEC’s enforcement division sent a subpoena to Abbott ABT, +0.62% in December requesting information about its powder infant-formula business and related public disclosures, the company said Friday in a securities filing.

In addition, Abbott said it received a civil investigative demand from the FTC in January seeking information in connection with the agency’s investigation of companies that bid for infant-formula supply contracts with a federal program.

Abbott, of Abbott Park, Ill., is cooperating with the government investigations, a spokesman said.

An expanded version of this report appears at WSJ.com.

Top stories from WSJ.com

Sen. John Fetterman Is Hospitalized for Depression

Facebook Parent Meta Gives Thousands of Workers Subpar Review

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More